Copyright
©The Author(s) 2023.
World J Clin Cases. Jul 6, 2023; 11(19): 4579-4600
Published online Jul 6, 2023. doi: 10.12998/wjcc.v11.i19.4579
Published online Jul 6, 2023. doi: 10.12998/wjcc.v11.i19.4579
Figure 5 The putative target of active Polygoni Cuspidati Rhizoma et Radix ingredients.
A: Biological processes analysis for targets of active ingredients of Polygoni Cuspidati Rhizoma et Radix; B: Kyoto Encyclopedia of Genes and Genomes pathways through enrichment method to indicate the top 10 signaling pathways of active ingredients of Polygoni Cuspidati Rhizoma et Radix. HIF-1: Hypoxia-inducible factor-1; TNF: Tumor necrosis factor; FDR: False discovery rate.
- Citation: Zheng JL, Wang X, Song Z, Zhou P, Zhang GJ, Diao JJ, Han CE, Jia GY, Zhou X, Zhang BQ. Network pharmacology and molecular docking to explore Polygoni Cuspidati Rhizoma et Radix treatment for acute lung injury. World J Clin Cases 2023; 11(19): 4579-4600
- URL: https://www.wjgnet.com/2307-8960/full/v11/i19/4579.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i19.4579